Table 1: Laboratory data, echocardiography, blood gas analysis and hemodynamic measurements between Pre and Post EPO treatment
Pre | Post | P value | |
Body weight (kg) | 53.0 ± 8.4 | 53.1 ± 8.6 | 0.976 |
Hct, (%) | 19.0 ± 2.5 | 32.9 ± 3.1 | < 0.001 |
Hb, (g/dl) | 6.4 ± 0.9 | 10.8 ± 1.0 | <0.001 |
Serum Epo, (mIU/ml) | 17.3 ± 4.5 | 19.3 ± 5.7 | 0.128 |
pH | 7.353 ± 0.036 | 7.339 ± 0.039 | 0.125 |
PaO2, (Torr) | 90.9 ± 14.8 | 90.9 ± 12.7 | 0.979 |
PaCO2, (Torr) | 35.7 ± 3.7 | 37.5 ± 3.6 | 0.046 |
HCO3-, (mmol/l) | 20.2 ± 2.4 | 20.2 ± 2.4 | 0.963 |
LVDd, (mm) | 51.3 ± 5.0 | 47.7 ± 5.4 | 0.006 |
LVDs, (mm) | 30.9 ± 4.6 | 29.5 ± 4.5 | 0.219 |
LVEF, (%) | 77.6 ± 6.7 | 75.8 ± 7.4 | 0.299 |
Cardiac Output, (L/min) | 7.97 ± 1.59 | 5.61 ± 1.21 | < 0.001 |
O2 delivery, (ml/min) | 663.8 ± 161.1 | 793.4 ± 188.5 | < 0.001 |